Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, July 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 271 articles:
HTML format


 

Single Articles

  1. MATHEW JM, Kumar A, Puthiyedath N
    Sacral insufficiency fracture after treatment for cervical cancer.
    Lancet Oncol. 2022;23:e359.
    PubMed    


  2. SELMOUNI F, Guy M, Muwonge R, Nassiri A, et al
    Effectiveness of artificial intelligence-assisted decision-making to improve vulnerable women's participation in cervical cancer screening in France: a cluster randomized controlled trial (AppDate-You).
    JMIR Res Protoc. 2022 Jun 3. doi: 10.2196/39288.
    PubMed    
    Abstract available

  3. JIN J, Du X, Zhou L, Yao D, et al
    SPI1-related protein inhibits cervical cancer cell progression and prevents macrophage cell migration.
    J Obstet Gynaecol Res. 2022 Jun 30. doi: 10.1111/jog.15336.
    PubMed    
    Abstract available

  4. SARASWATI W, Wardani R, Suhatno S, Hartono P, et al
    The Effect of Electroacupuncture Therapy on Pain, Plasma beta-Endorphin, and Quality of Life of Stage III Cervical Cancer Patients: A Randomized Control Trial.
    J Acupunct Meridian Stud. 2021;14:4-12.
    PubMed    
    Abstract available

  5. KORI M, Arga KY, Mardinoglu A, Turanli B, et al
    Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types.
    Front Pharmacol. 2022;13:884548.
    PubMed    
    Abstract available

  6. LIU L, Zhu H, Wang P, Wu S, et al
    Construction of a Six-Gene Prognostic Risk Model Related to Hypoxia and Angiogenesis for Cervical Cancer.
    Front Genet. 2022;13:923263.
    PubMed    
    Abstract available

  7. MENG L, Chen S, Shi G, He S, et al
    Use of Single Cell Transcriptomic Techniques to Study the Role of High-Risk Human Papillomavirus Infection in Cervical Cancer.
    Front Immunol. 2022;13:907599.
    PubMed    
    Abstract available

  8. ABRAHAM E, Fairley CK, Williams H, Morton A, et al
    How is cervical cancer screening discussed with clients at a sexual health clinic in Melbourne, Australia?
    Sex Health. 2022 Jun 30. pii: SH22093. doi: 10.1071/SH22093.
    PubMed    
    Abstract available

  9. LIMA FCDS, Souza BDSN, Oliveira JFP, Galvao ND, et al
    Cervical cancer specific survival in Grande Cuiaba, Mato Grosso State, Brazil.
    Rev Bras Epidemiol. 2022;25.
    PubMed    
    Abstract available

  10. WANG S, Zhang S
    Systematic analyses of a novel circRNA-related miRNAs prognostic signature for Cervical Cancer.
    Genet Mol Biol. 2022;45:e20210405.
    PubMed    
    Abstract available

  11. KANJANAWILAI N, Wisarnsirirak P, Chanthasenanont A, Pattaraarchachai J, et al
    Knowledge Attitude and Practice of Postpartum Parturients Towards Cervical Cancer and Cervical Cancer Screening; Is Lack of Knowledge the Misleading Scapegoat?
    Asian Pac J Cancer Prev. 2022;23:2145-2150.
    PubMed    
    Abstract available

  12. PUTRA SP, Putra AE, Astuti I, Asmara W, et al
    Human Papillomavirus Type 16 L2 Gene Sequence Variation Analysis in Indonesian Cervical Cancer Specimens.
    Asian Pac J Cancer Prev. 2022;23:2009-2016.
    PubMed    
    Abstract available

  13. UBAH C, Nwaneri AC, Anarado AN, Iheanacho PN, et al
    Perceived Barriers to Cervical Cancer Screening Uptake among Women of an Urban Community in South-Eastern Nigeria.
    Asian Pac J Cancer Prev. 2022;23:1959-1965.
    PubMed    
    Abstract available

  14. PARK J, Kim Y, Kim J, Kang S, et al
    Health-Related Quality of Life of Patients with Cervical Cancer According to the Duration of Treatment and Cancer Progression.
    Asian Pac J Cancer Prev. 2022;23:1945-1950.
    PubMed    
    Abstract available

  15. EGEMEN D, Perkins RB, Clarke MA, Guido R, et al
    Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are Available.
    J Low Genit Tract Dis. 2022;26:195-201.
    PubMed    
    Abstract available

  16. HARPER DM, Plegue M, Jimbo M, Sheinfeld Gorin S, et al
    US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
    Elife. 2022;11.
    PubMed    
    Abstract available

  17. CHEN Y, Wang S, Hu Q, Zhou L, et al
    Self-Emulsifying System Coloaded with Paclitaxel and Coix Seed Oil Deeply Penetrated to Enhance Efficacy of Cervical Cancer.
    Curr Drug Deliv. 2022 Jun 28. pii: CDD-EPUB-124831.
    PubMed    
    Abstract available

  18. CHEN C, Cao Y, Li W, Liu Z, et al
    The pathological risk score: A new deep learning-based signature for predicting survival in cervical cancer.
    Cancer Med. 2022 Jun 28. doi: 10.1002/cam4.4953.
    PubMed    
    Abstract available

  19. QIN Y, Zhao W
    The Modeling Analysis and Effect of CHI3L1 and CD31-Marked Microvessel Density in the Occurrence and Development of Cervical Squamous Cell Carcinoma.
    Comput Math Methods Med. 2022;2022:3516335.
    PubMed    
    Abstract available

  20. HUANG C, Lv X, Chen P, Liu J, et al
    Human papillomavirus targets the YAP1-LATS2 feedback loop to drive cervical cancer development.
    Oncogene. 2022 Jun 27. pii: 10.1038/s41388-022-02390.
    PubMed    
    Abstract available

  21. SUGIYAMA T, Katsumata N, Toita T, Ura M, et al
    Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.
    Int J Clin Oncol. 2022 Jun 27. pii: 10.1007/s10147-022-02196.
    PubMed    
    Abstract available

  22. PARK H, Seo SH, Park JH, Yoo SH, et al
    The impact of COVID-19 on the screening of colorectal, gastric, breast and cervical cancer in Korea.
    Epidemiol Health. 2022 Jun 21:e2022053. doi: 10.4178/epih.e2022053.
    PubMed    
    Abstract available

  23. PU G, Jiang S, Yang Z, Hu Y, et al
    A novel ultrasound probe calibration method for multimodal image guidance of needle placement in cervical cancer brachytherapy.
    Phys Med. 2022;100:81-89.
    PubMed    
    Abstract available

  24. BELTRAN-GUERRERO LJ, Garcia-Valdez R, Andrade-Amador V, Vazquez-Arguelles L, et al
    [Comparison of the Pap smear with conventional technique versus modified technique].
    Rev Med Inst Mex Seguro Soc. 2022;60:164-170.
    PubMed    
    Abstract available

  25. MOHAMMAD Z, Ahmad N, Baharom A
    The Effects of Theory-Based Educational Intervention and WhatsApp Follow-up on Papanicolaou Smear Uptake Among Postnatal Women in Malaysia: Randomized Controlled Trial.
    JMIR Mhealth Uhealth. 2022;10:e32089.
    PubMed    
    Abstract available

  26. TIZAOUI K, Jalouli M, Boujelbene N, Harrath AH, et al
    The relationship of 3'UTR HLA-G14-bp insertion/deletion and +3142 C/G polymorphisms and soluble HLA-G expression with gynecological cancers: An updated meta-analysis.
    Immun Inflamm Dis. 2022;10:e645.
    PubMed    
    Abstract available

  27. OH J, Oda K, Dang K, Ibrayev Y, et al
    Lower Compliance with Cervical Cancer Screening Guidelines Among Vegetarians in North America.
    J Prev (2022). 2022 Jun 27. pii: 10.1007/s10935-022-00691.
    PubMed    
    Abstract available

  28. SU Y, Tang Y, Zhang T, Xu Y, et al
    Methylated ZNF582 as a triage marker for occult cervical cancer and advanced cervical intraepithelial neoplasia.
    Future Oncol. 2022 Jun 27. doi: 10.2217/fon-2021-1625.
    PubMed    
    Abstract available

  29. TANG L, Xing Y, Li H
    Construction of Nursing Practice Model in Case Management of Concurrent Chemotherapy and Radiochemotherapy Treatment in Cervical Cancer.
    Appl Bionics Biomech. 2022;2022:5450575.
    PubMed    
    Abstract available

  30. MIRI SM, Pourhossein B, Hosseini SY, Keshavarz M, et al
    Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade.
    Virol J. 2022;19:106.
    PubMed    
    Abstract available

  31. PAL A, Das S, Basu S, Kundu R, et al
    Apoptotic and autophagic death union by Thuja occidentalis homeopathic drug in cervical cancer cells with thujone as the bioactive principle.
    J Integr Med. 2022 Jun 15. pii: S2095-4964(22)00070.
    PubMed    
    Abstract available

  32. MAJID E, Shaikh MA, Qazi OA, Khan S, et al
    Awareness, screening, practices and attitudes of cervical cancer among doctors and nursing staff working at a tertiary care centre.
    J Pak Med Assoc. 2022;72:1025-1030.
    PubMed    
    Abstract available

  33. CAMBREA SC, Aschie M, Resul G, Mitroi AF, et al
    HPV and HIV Coinfection in Women from a Southeast Region of Romania-PICOPIV Study.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  34. LI L, Guo Q, Lan G, Liu F, et al
    Construction of a four-mRNA prognostic signature with its ceRNA network in CESC.
    Sci Rep. 2022;12:10691.
    PubMed    
    Abstract available

  35. TODD B
    HPV-Associated Cancer Trends Since Vaccine Initiation.
    Am J Nurs. 2022;122:62-63.
    PubMed    
    Abstract available

  36. A V MARLOW L, Nemec M, Barnes J, Waller J, et al
    Testing key messages about extending cervical screening intervals.
    Patient Educ Couns. 2022;105:2757-2762.
    PubMed    
    Abstract available

  37. AGUIAR TD, Valente RP, Figueiredo AR, Beires JM, et al
    Risk Factors for Positive Margins in High-Grade Cervical Intraepithelial Neoplasia After Transformation Zone Excision.
    J Low Genit Tract Dis. 2022;26:207-211.
    PubMed    
    Abstract available

  38. FISH R
    Ovarian transposition in rectal cancer: uncertain benefit at a high price.
    Colorectal Dis. 2022;24:706-707.
    PubMed    


  39. LEE HY, Luo Y, Daniel C, Wang K, et al
    Is HPV vaccine awareness associated with HPV knowledge level? Findings from HINTS data across racial/ethnic groups in the US.
    Ethn Health. 2022;27:1166-1177.
    PubMed    
    Abstract available

  40. RANDALL LM
    The role of immunotherapy in recurrent or metastatic cervical cancer.
    Clin Adv Hematol Oncol. 2022;20:435-437.
    PubMed    


  41. SUN S, Wang X, Chen Y
    The Application Value of CT Three-Dimensional Microscope Reconstruction Technology in the Diagnosis of Cervical Cancer.
    Scanning. 2022;2022:5648195.
    PubMed    
    Abstract available

  42. UTAMI TW, Andrijono A, Putra A, Indarti J, et al
    Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study.
    Clin Exp Vaccine Res. 2022;11:141-148.
    PubMed    
    Abstract available

  43. WANG W, Wu L, Tian J, Yan W, et al
    Cervical Cancer Cells-Derived Extracellular Vesicles Containing microRNA-146a-5p Affect Actin Dynamics to Promote Cervical Cancer Metastasis by Activating the Hippo-YAP Signaling Pathway via WWC2.
    J Oncol. 2022;2022:4499876.
    PubMed    
    Abstract available

  44. TANG Y, Qiao C, Li Q, Zhu X, et al
    Research Progress in the Relationship Between P2X7R and Cervical Cancer.
    Reprod Sci. 2022 Jul 7. pii: 10.1007/s43032-022-01022.
    PubMed    
    Abstract available

  45. ALVES TP, Pereira MTM, Charret TS, Thurler-Junior JC, et al
    Evaluation of the antiproliferative potential of Eugenia pyriformis leaves in cervical cancer cells.
    Chem Biodivers. 2022 Jul 7. doi: 10.1002/cbdv.202200114.
    PubMed    
    Abstract available

  46. CHEN Z, Qiu J, Gao Y, Lu Q, et al
    Correction to: Study on the mechanism of let7a5p in regulating the proliferation in cervical cancer cells.
    Clin Transl Oncol. 2022 Jul 7. pii: 10.1007/s12094-022-02878.
    PubMed    


  47. WANG X, Dai Y, Zhang J, Li X, et al
    Annexin A5 suppression promotes the progression of cervical cancer.
    Arch Gynecol Obstet. 2022 Jul 7. pii: 10.1007/s00404-022-06524.
    PubMed    
    Abstract available

  48. HOU D, Yang B, Li Y, Sun M, et al
    Utility of Scoring System for Screening and Early Warning of Cervical Cancer Based on Big Data Analysis.
    Front Public Health. 2022;10:920956.
    PubMed    
    Abstract available

  49. LINTAO RCV, Cando LFT, Perias GAS, Tantengco OAG, et al
    Current Status of Human Papillomavirus Infection and Cervical Cancer in the Philippines.
    Front Med (Lausanne). 2022;9:929062.
    PubMed    
    Abstract available

  50. HE H, Mi J, Su Y, Wang B, et al
    Analysis of the Clinical Value of MAGE-A9 Expressions in Cervical Cancer Tissues and PBMC.
    Emerg Med Int. 2022;2022:1417752.
    PubMed    
    Abstract available

  51. DAMGAARD RK, Jenkins D, de Koning MN, Quint WG, et al
    Performance of HPV E4 and p16(INK4a) biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study.
    BMJ Open. 2022;12:e059593.
    PubMed    
    Abstract available

  52. NYGARD M, Engesaeter B, Castle PE, Berland JM, et al
    Randomized implementation of a primary human papillomavirus testing-based cervical cancer screening protocol for women 34 to 69 years in Norway.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 6. pii: 706897.
    PubMed    
    Abstract available

  53. KANG Z, Fu L, Liu J, Shi L, et al
    A practical method to improve the performance of knowledge-based VMAT planning for endometrial and cervical cancer.
    Acta Oncol. 2022 Jul 6:1-7. doi: 10.1080/0284186X.2022.2093615.
    PubMed    
    Abstract available

  54. MINCIUNA CE, Bitere O, Lacatus M, Tudor S, et al
    Is There a Role for Minimally Invasive Surgery in Cervical Cancer Treatment: Carry on, Discard, or Modify? A Literature Review and Case Series Presentation.
    Chirurgia (Bucur). 2022;117:258-265.
    PubMed    
    Abstract available

  55. NISHIO S, Yonemori K, Usami T, Minobe S, et al
    Pembrolizumab Plus Chemotherapy in Japanese Patients With Persistent, Recurrent or Metastatic Cervical Cancer: Results From KEYNOTE-826.
    Cancer Sci. 2022 Jul 6. doi: 10.1111/cas.15479.
    PubMed    
    Abstract available

  56. ROYCHOWDHURY A, Basu M, Pal D, Dutta P, et al
    PTPRJ is downregulated in cervical squamous cell carcinoma.
    J Genet. 2022;101.
    PubMed    
    Abstract available

  57. ZHOU H, Tian J, Sun H, Fu J, et al
    Systematic Identification of Genomic Markers for Guiding Iron Oxide Nanoparticles in Cervical Cancer Based on Translational Bioinformatics.
    Int J Nanomedicine. 2022;17:2823-2841.
    PubMed    
    Abstract available

  58. LEE K, Lee YY, Suh M, Jun JK, et al
    Impact of COVID-19 on cancer screening in South Korea.
    Sci Rep. 2022;12:11380.
    PubMed    
    Abstract available

  59. SAMAILA A, Isah A, Biambo AA, Usman N, et al
    Development and reliability testing of a cervical cancer patients knowledge and practice of self-care management of treatment-related adverse events questionnaire.
    J Oncol Pharm Pract. 2022 Jul 5:10781552221112159.
    PubMed    
    Abstract available

  60. IMAMURA A, Oike T, Sato H, Yoshimoto Y, et al
    Comparative Analysis of the Antitumor Immune Profiles of Paired Radiotherapy-naive and Radiotherapy-treated Cervical Cancer Tissues.
    Anticancer Res. 2022;42:3341-3348.
    PubMed    
    Abstract available

  61. TU J, Chen S, Wu S, Wu T, et al
    Tumor DNA Methylation Profiles Enable Diagnosis, Prognosis Prediction, and Screening for Cervical Cancer.
    Int J Gen Med. 2022;15:5809-5821.
    PubMed    
    Abstract available

  62. CAI Y, Zhang J, Xin T, Xu S, et al
    Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses.
    J Pharm Pharmacol. 2022 Jul 5. pii: 6631270. doi: 10.1093.
    PubMed    
    Abstract available

  63. LIU Y, Huang S, Li Z
    Comparison of adverse events in laparoscopic surgery versus open surgery on cervical cancer.
    Asian J Surg. 2022 Jul 1. pii: S1015-9584(22)00881.
    PubMed    


  64. LI LL, Cui YY, Gao PY, Xia L, et al
    [Clinicopathological features of mixed cervical carcinoma with adenoid cystic pattern].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:615-620.
    PubMed    
    Abstract available

  65. ZHOU XR
    [Development and task of gynecologic pathology].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:581-584.
    PubMed    
    Abstract available

  66. WU Z, Huang C, Li R, Li H, et al
    PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer.
    Front Oncol. 2022;12:887139.
    PubMed    
    Abstract available

  67. VAN TRAPPEN P, De Cuypere E, Claes N, Roels S, et al
    Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series.
    Front Surg. 2022;9:905083.
    PubMed    
    Abstract available

  68. SHI Y, Wu Z, Wang H, Kong W, et al
    The Influence of Family-Oriented Enabling Psychological Nursing on Posttraumatic Stress and Fear of Recurrence in Patients with Cervical Cancer.
    Evid Based Complement Alternat Med. 2022;2022:6720287.
    PubMed    
    Abstract available

  69. FOGARASI AI, Benczik M, Moravcsik-Kornyicki A, Kocsis A, et al
    The Prevalence of High-Risk Human Papillomavirus in Hungary-A Geographically Representative, Cross-Sectional Study.
    Pathol Oncol Res. 2022;28:1610424.
    PubMed    
    Abstract available

  70. QIU Z, He L, Yu F, Lv H, et al
    LncRNA FAM13A-AS1 Regulates Proliferation and Apoptosis of Cervical Cancer Cells by Targeting miRNA-205-3p/DDI2 Axis.
    J Oncol. 2022;2022:8411919.
    PubMed    
    Abstract available

  71. WANG X, Wang H, Mou X, Xu Y, et al
    Lysophosphatidic acid protects cervical cancer HeLa cells from apoptosis induced by doxorubicin hydrochloride.
    Oncol Lett. 2022;24:267.
    PubMed    
    Abstract available

  72. CUI H, Ma R, Hu T, Xiao GG, et al
    Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment.
    Front Cell Infect Microbiol. 2022;12:926348.
    PubMed    
    Abstract available

  73. GROVER S, Luckett R, Bhatia RK, Ralefala T, et al
    Neoadjuvant chemotherapy and less invasive surgery for the management of early stage cervical cancer: A brief report from Botswana.
    Gynecol Oncol Rep. 2022;42:101032.
    PubMed    
    Abstract available

  74. SOARES LC, Junior JCD, de Souza RJ, de Oliveira MAP, et al
    Critical Analysis of the FIGO 2018 Cervical Cancer Staging.
    J Turk Ger Gynecol Assoc. 2022 Jul 5. doi: 10.4274/jtgga.galenos.2022.2022.
    PubMed    


  75. LIU M, Wei D, Nie Q, Peng L, et al
    Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
    Taiwan J Obstet Gynecol. 2022;61:663-671.
    PubMed    
    Abstract available

  76. NOVACKOVA M, Pastor Z, Chmel R Jr, Mala I, et al
    Sexuality and quality of life after nerve-sparing radical hysterectomy for cervical cancer: A prospective study.
    Taiwan J Obstet Gynecol. 2022;61:641-645.
    PubMed    
    Abstract available

  77. YANG ST, Liu CH, Wang PH
    No impact of tumor size on oncological outcomes in cervical cancer patients after radical hysterectomy and postoperative radiotherapy: Is it real?
    Taiwan J Obstet Gynecol. 2022;61:575-577.
    PubMed    


  78. ROJAS-ZUMARAN V, Moya-Salazar J, Walttuoni E, Reyes-Vega M, et al
    [The importance of Hashime Murayama's illustrations for George Papanicolaou's Atlas of exfoliative cytology].
    Rev Esp Patol. 2022;55:173-180.
    PubMed    
    Abstract available

  79. WU P, Qin J, Liu L, Tan W, et al
    circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer.
    Aging (Albany NY). 2022;14.
    PubMed    
    Abstract available

  80. SHUKLA S, Sah AN, Hatiboruah D, Ahirwar S, et al
    Design, fabrication and testing of 3D printed smartphone-based device for collection of intrinsic fluorescence from human cervix.
    Sci Rep. 2022;12:11192.
    PubMed    
    Abstract available

  81. PANG H, Lai Q, Liu G, Song Q, et al
    Pelvic bones ADC could help to predict severe hematologic toxicity in patients undergoing concurrent chemoradiotherapy for cervical cancer.
    Magn Reson Imaging. 2022 Jun 28. pii: S0730-725X(22)00101.
    PubMed    
    Abstract available

  82. GUO Y, Bai Y, Wang L, Xu Z, et al
    The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Medicine (Baltimore). 2022;101:e29818.
    PubMed    
    Abstract available

  83. KIM SI, Kim JW
    Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening.
    J Gynecol Oncol. 2022;33:e65.
    PubMed    


  84. BATTAGELLO J, Monetti D, Rizzato S, Rosano A, et al
    Young immigrant women and cervical cancer screening: participation and lesions detected at the first screening round.
    Epidemiol Prev. 2022;46:173-180.
    PubMed    
    Abstract available

  85. NAIR UN, Madhivanan P, Saad ER, Adsul P, et al
    Multi-Level Factors Are Associated with Uptake of Cervical Cancer Screening in Sexual and Gender Diverse Adults Residing in Arizona.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1510.
    PubMed    
    Abstract available

  86. SONG M, Meng Q, Jiang X, Liu J, et al
    Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway.
    J Cell Mol Med. 2022 Jun 30. doi: 10.1111/jcmm.17439.
    PubMed    
    Abstract available

  87. DI NAPOLI A, Ventura M, Grande E, Frova L, et al
    Nationwide longitudinal population-based study on mortality in Italy by immigrant status.
    Sci Rep. 2022;12:10986.
    PubMed    
    Abstract available

  88. SOUZA BDSN, Melanda FN, Lima FCDS, Silva PFO, et al
    Incidence trend of five main causes of cancer, in greater Cuiaba, Mato Grosso, Brazil, 2000 to 2016.
    Rev Bras Epidemiol. 2022;25.
    PubMed    
    Abstract available

  89. OLIVEIRA JCS, Castelo LM, Soares MR, Magalhaes AS, et al
    Incidence and Mortality by the Main Types of Cancer in the City of Cuiaba, Mato Grosso, Between the Years of 2008 and 2016.
    Rev Bras Epidemiol. 2022;25.
    PubMed    
    Abstract available

  90. MA ZY, Zhu YF, Liu ZH, Zhu HY, et al
    [Expression of PD-L1 and tumor infiltrating lymphocyte markers in uterine cervical carcinoma].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:602-607.
    PubMed    
    Abstract available

  91. LI YM, He YY, Sun PL, Gao HW, et al
    [Correlation of micropapillary patten, cribriform pattern and retraction clefting of endocervical adenocarcinoma with the Silva classification system and prognosis].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:596-601.
    PubMed    
    Abstract available

  92. SHING JZ, Hu S, Herrero R, Hildesheim A, et al
    Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
    Lancet Oncol. 2022;23:940-949.
    PubMed    
    Abstract available

  93. GIM G, Kim Y, Park Y, Kim MJ, et al
    Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
    Oncologist. 2022;27:525-531.
    PubMed    
    Abstract available

  94. YOSHINO K, Kurita T, Takahashi F, Nagase S, et al
    Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014.
    J Obstet Gynaecol Res. 2022;48:1570-1579.
    PubMed    
    Abstract available

  95. HIKARI T, Honda A, Hashiguchi M, Okuma R, et al
    The difference in the effectiveness of human papillomavirus vaccine based on smoking status.
    J Obstet Gynaecol Res. 2022;48:1859-1866.
    PubMed    
    Abstract available

  96. CORTES KG, Kallis K, Simon A, Mayadev J, et al
    Knowledge-based three-dimensional dose prediction for tandem-and-ovoid brachytherapy.
    Brachytherapy. 2022;21:532-542.
    PubMed    
    Abstract available

  97. STANCZUK G, Currie H, Forson W, Baxter G, et al
    Clinical Performance of Triage Strategies for Hr-HPV-Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1492-1498.
    PubMed    
    Abstract available

  98. LI J, Zhao C, Wu R, Li M, et al
    Characteristics of genotypes and prevalence of high-risk human papillomavirus in different economic development regions in China.
    J Infect. 2022;85:174-211.
    PubMed    


  99. ZHANG L, Nan F, Yang L, Dong Y, et al
    Differentially expressed EREG and SPP1 are independent prognostic markers in cervical squamous cell carcinoma.
    J Obstet Gynaecol Res. 2022;48:1848-1858.
    PubMed    
    Abstract available

  100. CHIVA L, Manzour N
    ASO Author Reflections: Will Conization Become a Standard Maneuver Before Radical Hysterectomy?
    Ann Surg Oncol. 2022;29:4830-4831.
    PubMed    


  101. LITMAN EA, Cigna ST
    Female Sexual Dysfunction in Women After Treatment of Cervical Dysplasia.
    Sex Med Rev. 2022;10:360-366.
    PubMed    
    Abstract available

  102. REBOLJ M, Mathews CS, Denton K
    Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot.
    Cancer Cytopathol. 2022;130:531-541.
    PubMed    
    Abstract available

  103. WANG H, He Z, Han X, Zhang D, et al
    Prediction value with a novel and accurate tissue-based human papillomavirus detection method in low-grade squamous intraepithelial lesions.
    Cancer Med. 2022;11:2576-2587.
    PubMed    
    Abstract available

  104. YU XQ, Feletto E, Smith MA, Yuill S, et al
    Cancer Incidence in Migrants in Australia: Patterns of Three Infection-Related Cancers.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1394-1401.
    PubMed    
    Abstract available

  105. CHEN AC, Kim WS, Todd M, Larkey L, et al
    A Digital Storytelling Intervention for Vietnamese American Mothers to Promote Their Children's HPV Vaccination.
    Cancer Prev Res (Phila). 2022;15:465-472.
    PubMed    
    Abstract available

  106. TAO X, Zhang H, Zhang H, Xiao Y, et al
    The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Cancer Cytopathol. 2022;130:542-550.
    PubMed    
    Abstract available

  107. LOZARES-CORDERO S, Gonzalez-Perez V, Pellejero-Pellejero S, Rodriguez-Ruiz L, et al
    Feasibility of electronic brachytherapy in cervix cancer-A dosimetric comparison of different brachytherapy techniques.
    Brachytherapy. 2022;21:389-396.
    PubMed    
    Abstract available

  108. SHOAIB S, Islam N, Yusuf N
    Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy.
    Curr Med Chem. 2022;29:4481-4506.
    PubMed    
    Abstract available

  109. TSAI JW, Lee JC, Hsieh TH, Huang SC, et al
    Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
    Mod Pathol. 2022;35:911-921.
    PubMed    
    Abstract available

  110. CHADWICK V, Bennett KF, McCaffery KJ, Brotherton JML, et al
    Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus-based cervical screening program: A cross-sectional survey.
    Psychooncology. 2022;31:1110-1119.
    PubMed    
    Abstract available

  111. NAGANO S, Kitadani J, Ojima T, Hayata K, et al
    Pharyngolaryngectomy with thoracoscopic esophagectomy via the left thoracic approach for cervical esophageal cancer with right aortic arch: Case report.
    Asian J Endosc Surg. 2022;15:647-651.
    PubMed    
    Abstract available

  112. BOGALE AL, Teklehaymanot T, Kassie GM, Medhin G, et al
    Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.
    Cancer Control. 2022;29:10732748221114980.
    PubMed    
    Abstract available

  113. LIN S, Li X, Zhang Y, Mao X, et al
    Manifestation of Urinary Tract Injury during Cervical Cancer Surgery Based on CT Urography Secretion Phase Images.
    Contrast Media Mol Imaging. 2022;2022:2572681.
    PubMed    
    Abstract available

  114. WANG Y, Shen L, Jin J, Wang G, et al
    Application and Clinical Value of Machine Learning-Based Cervical Cancer Diagnosis and Prediction Model in Adjuvant Chemotherapy for Cervical Cancer: A Single-Center, Controlled, Non-Arbitrary Size Case-Control Study.
    Contrast Media Mol Imaging. 2022;2022:2432291.
    PubMed    
    Abstract available

  115. YAO LQ, Zou RY, Yuan L, Chen M, et al
    [Laterally extended endopelvic resection for advanced or recurrent gynecological malignancies: clinicopathological analysis].
    Zhonghua Yi Xue Za Zhi. 2022;102:2026-2029.
    PubMed    
    Abstract available

  116. LI N, Chen RZ, Wang FF, Li BH, et al
    [Preoperative serum creatinine as an independent prognostic biomarker in patients with early-stage cervical adenocarcinoma].
    Zhonghua Yi Xue Za Zhi. 2022;102:1993-1998.
    PubMed    
    Abstract available

  117. LING KJ, Liang ZQ
    [Current situation and deliberating the application of open or minimally invasive surgery for the cervical cancer].
    Zhonghua Yi Xue Za Zhi. 2022;102:1967-1972.
    PubMed    
    Abstract available

  118. MA D
    [The opportunities and challenges of gynecologic cancer in precision medicine].
    Zhonghua Yi Xue Za Zhi. 2022;102:1963-1966.
    PubMed    
    Abstract available

  119. GUO Z, Zhu T, Zhou Y, Si T, et al
    The relationship between HPV prevalence and DNA damage in cervical cancer population in Gansu province, China.
    Intervirology. 2022 Jul 12. pii: 000525975. doi: 10.1159/000525975.
    PubMed    
    Abstract available

  120. SHIGETA S, Shimada M, Tsuji K, Nagai T, et al
    Correction to: Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group.
    Int J Clin Oncol. 2022 Jul 11. pii: 10.1007/s10147-022-02211.
    PubMed    


  121. SWAMI D, Mudaliar P, Bichu YS, Kumar Sahu V, et al
    Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and in vitro insight.
    J Biomol Struct Dyn. 2022 Jul 12:1-15. doi: 10.1080/07391102.2022.2097312.
    PubMed    
    Abstract available

  122. CHANG A, Wang P, Ren J
    LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer.
    Med Sci Monit. 2022;28:e935070.
    PubMed    
    Abstract available

  123. WEN N, Zhang J, Zhang Q
    MiR-494 Inhibits the Proliferation, Migration and Invasion of Cervical Cancer Cells by Regulating LETMD1.
    Cell Mol Biol (Noisy-le-grand). 2022;67:81-87.
    PubMed    
    Abstract available

  124. ZHENG Z, Yang X, Yu Q, Li L, et al
    The regulating role of miR-494 on HCCR1 in cervical cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2022;67:131-137.
    PubMed    
    Abstract available

  125. YU T, Wang C
    Clinical Significance of Detection of Human Papilloma Virus DNA and E6/E7 mRNA for Cervical Cancer Patients.
    Cell Mol Biol (Noisy-le-grand). 2022;67:155-159.
    PubMed    
    Abstract available

  126. DE OLIVEIRA GS, da Silva GRP, Aquino MLC, Dos Santos Oliveira F, et al
    Trends in cervical cancer mortality rate in women aged 20 years and older in Brazil from 2005 to 2019.
    Women Health. 2022 Jul 11:1-12. doi: 10.1080/03630242.2022.2094045.
    PubMed    
    Abstract available

  127. MOYA-SALAZAR J, Salazar-Hernandez R, Rojas-Zumaran V, Cruz-Gonzales G, et al
    Cost and pollution by the use of xylene in cervical cytology in four Peruvian hospitals.
    F1000Res. 2021;10:848.
    PubMed    
    Abstract available

  128. XU H, Tang Y, He C, Tian Y, et al
    Prognostic value of lncRNA HOXA-AS3 in cervical cancer by targeting miR-29a-3p and its regulatory effect on tumor progression.
    J Obstet Gynaecol Res. 2022 Jul 11. doi: 10.1111/jog.15360.
    PubMed    
    Abstract available

  129. MA GY, Shi S, Ma HY, Zhang ZG, et al
    Roles of Beclin1 protein expression in cervical cancer: a meta-analysis and bioinformatics analysis.
    J Obstet Gynaecol. 2022 Jul 9:1-9. doi: 10.1080/01443615.2022.2091924.
    PubMed    
    Abstract available

  130. WEI W, Xie LZ, Xia Q, Fu Y, et al
    The role of vaginal microecology in the cervical cancer.
    J Obstet Gynaecol Res. 2022 Jul 11. doi: 10.1111/jog.15359.
    PubMed    
    Abstract available

  131. MICHA JP, Rettenmaier MA, Bohart RD, Goldstein BH, et al
    Robotic-Assisted Surgery for the Treatment of Breast and Cervical Cancers.
    JSLS. 2022;26.
    PubMed    
    Abstract available

  132. GODOY-PACHECO A, Garcia-Chagollan M, Ramirez-De-Arellano A, Hernandez-Silva CD, et al
    Differential modulation of natural killer cell cytotoxicity by 17beta-estradiol and prolactin through the NKG2D/NKG2DL axis in cervical cancer cells.
    Oncol Lett. 2022;24:288.
    PubMed    
    Abstract available

  133. WU M, Han Y, Gong X, Wan K, et al
    Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target.
    Front Med (Lausanne). 2022;9:759928.
    PubMed    
    Abstract available

  134. LI X, Cheng Y, Cheng Y, Shi H, et al
    Transcriptome Analysis Reveals the Immune Infiltration Profiles in Cervical Cancer and Identifies KRT23 as an Immunotherapeutic Target.
    Front Oncol. 2022;12:779356.
    PubMed    
    Abstract available

  135. FENG Y, Wang Z, Zhu M, Li S, et al
    Single Nucleotide Polymorphisms of EXOC1, BCL2, CCAT2, and CARD8 Genes and Susceptibility to Cervical Cancer in the Northern Chinese Han Population.
    Front Oncol. 2022;12:878529.
    PubMed    
    Abstract available

  136. TESFAYE B, Tilahun T, Dechasa Heyi W, Oljira R, et al
    Associated factors of positive visual inspection of cervix with acetic acid test among women screened for cervical cancer at public health facilities in Woliso town, Southwest Shoa, Ethiopia: A case-control study.
    SAGE Open Med. 2022;10:20503121221108227.
    PubMed    
    Abstract available

  137. AL KALBANI R, Al Kindi R, Al Basami T, Al Awaisi H, et al
    Cervical Cancer-related Knowledge and Practice among Omani Women Attending a Family Medicine and Public Health Clinic.
    Oman Med J. 2022;37:e374.
    PubMed    
    Abstract available

  138. MUNTYANU A, Nechaev V, Pastukhova E, Logan J, et al
    Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study.
    Lancet Reg Health Eur. 2022;20:100454.
    PubMed    
    Abstract available

  139. HURNI Y, Huber DE
    Sentinel Node Biopsy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery in a Patient with Early-Stage Cervical Cancer: A Case Report.
    Case Rep Oncol. 2022;15:547-552.
    PubMed    
    Abstract available

  140. LU Q, Wu L, Qi L, Tie P, et al
    Effect of Comprehensive Care Based on Appropriate Chinese Medicine Techniques on Urinary Retention and Bladder Function Recovery after Total Hysterectomy in Patients with Cervical Cancer.
    Comput Math Methods Med. 2022;2022:7495418.
    PubMed    
    Abstract available

  141. CHUNG JF, Chen CL, Nassef Y, Shiu BH, et al
    Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.
    Int J Med Sci. 2022;19:1013-1022.
    PubMed    
    Abstract available

  142. LI C, Hua K
    Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes.
    Front Immunol. 2022;13:897366.
    PubMed    
    Abstract available

  143. LU E, Hu X, Pan C, Chen J, et al
    Erratum: Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer: Erratum.
    J Cancer. 2022;13:2727-2728.
    PubMed    
    Abstract available

  144. HU XL, Huang XT, Zhang JN, Liu J, et al
    Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1alpha and promotes cervical cancer progression.
    Am J Cancer Res. 2022;12:2783-2797.
    PubMed    
    Abstract available

  145. CASTLE PE, Befano B, Schiffman M, Wentzensen N, et al
    A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening.
    Prev Med. 2022 Jul 7:107157. doi: 10.1016/j.ypmed.2022.107157.
    PubMed    
    Abstract available

  146. GININDZA TG, Forestier M, Almonte M
    Cervical cancer screening by visual inspection and HPV testing in Eswatini.
    Prev Med. 2022 Jul 7:107144. doi: 10.1016/j.ypmed.2022.107144.
    PubMed    
    Abstract available

  147. BHATTACHARJEE R, Dey T, Kumar L, Kar S, et al
    Cellular landscaping of cisplatin resistance in cervical cancer.
    Biomed Pharmacother. 2022;153:113345.
    PubMed    
    Abstract available

  148. DAS AP, Chopra M, Agarwal SM
    Prioritization and Meta-analysis of regulatory SNPs identified IL6, TGFB1, TLR9 and MMP7 as significantly associated with cervical cancer.
    Cytokine. 2022;157:155954.
    PubMed    
    Abstract available

  149. MA CY, Zhou JY, Xu XT, Qin SB, et al
    Clinical evaluation of deep learning-based clinical target volume three-channel auto-segmentation algorithm for adaptive radiotherapy in cervical cancer.
    BMC Med Imaging. 2022;22:123.
    PubMed    
    Abstract available

  150. LIANG LA, Zeissig SR, Schauberger G, Merzweiler S, et al
    Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study.
    BMC Womens Health. 2022;22:285.
    PubMed    
    Abstract available

  151. MARZHOSEYNI Z, Shayestehpour M, Salimian M, Esmaeili D, et al
    Designing a novel fusion protein from Streptococcus agalactiae with apoptosis induction effects on cervical cancer cells.
    Microb Pathog. 2022;169:105670.
    PubMed    
    Abstract available

  152. WANG XL, Cao XZ, Wang DY, Qiu YB, et al
    Casticin Attenuates Stemness in Cervical Cancer Stem-Like Cells by Regulating Activity and Expression of DNMT1.
    Chin J Integr Med. 2022 Jul 9. pii: 10.1007/s11655-022-3469.
    PubMed    
    Abstract available

  153. CHIANG YF, Chung CP, Lin JH, Chiang W, et al
    Adlay Seed (Coix lacryma-jobi L. var. Ma-yuen Stapf.) Ethanolic Extract Fractions and Subfractions Induce Cell Cycle Arrest and Apoptosis in Human Breast and Cervical Cancer Cell Lines.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  154. GARDELLA B, Pasquali MF, La Verde M, Cianci S, et al
    The Complex Interplay between Vaginal Microbiota, HPV Infection, and Immunological Microenvironment in Cervical Intraepithelial Neoplasia: A Literature Review.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  155. CONDIC M, Ralser DJ, Klumper N, Ellinger J, et al
    Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  156. CHOI PW, Liu TL, Wong CW, Liu SK, et al
    The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  157. CRUZ-DE LA ROSA MI, Jimenez-Wences H, Alarcon-Millan J, Romero-Lopez MJ, et al
    miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  158. BITAR H, Babour A, Nafa F, Alzamzami O, et al
    Increasing Women's Knowledge about HPV Using BERT Text Summarization: An Online Randomized Study.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  159. WANG Q, Sudan K, Schmoeckel E, Kost BP, et al
    CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model.
    Cells. 2022;11.
    PubMed    
    Abstract available

  160. TEN EIKELDER MLG, Hinten F, Smits A, Van der Aa MA, et al
    Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort Study.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  161. NILIMA N, Mani K, Kaushik S, Rai SN, et al
    Cervical Cancer Screening and Associated Barriers among Women in India: A Generalized Structural Equation Modeling Approach.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  162. ENOMOTO S, Yoshihara K, Kondo E, Iwata A, et al
    Trends in Pregnancy-Associated Cervical Cancer in Japan between 2012 and 2017: A Multicenter Survey.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  163. HE ZY, Li HY, Yan J, Li SJ, et al
    A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical.
    Trials. 2022;23:556.
    PubMed    
    Abstract available

  164. YU H, Ma L, Bian M, Li Q, et al
    Association of abnormal vaginal microflora and HPV infection in cervical precancerous lesions: a retrospective study.
    J Infect Dev Ctries. 2022;16:1089-1095.
    PubMed    
    Abstract available

  165. HIRKO KA, Xu H, Rogers LQ, Martin MY, et al
    Cancer disparities in the context of rurality: risk factors and screening across various U.S. rural classification codes.
    Cancer Causes Control. 2022;33:1095-1105.
    PubMed    
    Abstract available

  166. WHITE MC, Weir HK, Soman AV, Peipins LA, et al
    Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.
    Cancer Causes Control. 2022;33:1121-1124.
    PubMed    
    Abstract available

  167. ZHANG J, Li Y, Ren Y, Han H, et al
    Mir-326 potentiates radiosensitivity of cervical squamous cell carcinoma through downregulating SMO expression in the Hedgehog signaling pathway.
    Genes Genomics. 2022;44:981-991.
    PubMed    
    Abstract available

  168. CHANG X, Cai X, Dan Y, Song Y, et al
    Self-supervised learning for multi-center magnetic resonance imaging harmonization without traveling phantoms.
    Phys Med Biol. 2022;67.
    PubMed    
    Abstract available

  169. YANG M, Du J, Lu H, Xiang F, et al
    Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease.
    BMJ Open. 2022;12:e055470.
    PubMed    
    Abstract available

  170. RHEE DJ, Jhingran A, Huang K, Netherton TJ, et al
    Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques.
    Med Phys. 2022 Jul 22. doi: 10.1002/mp.15868.
    PubMed    
    Abstract available

  171. HAMDIUI N, Bouman MPA, Stein ML, Crutzen R, et al
    The development of a culturally sensitive educational video: How to facilitate informed decisions on cervical cancer screening among Turkish- and Moroccan-Dutch women.
    Health Expect. 2022 Jul 21. doi: 10.1111/hex.13545.
    PubMed    
    Abstract available

  172. JIANG B, Tian Q, Shu C, Zhao J, et al
    Resveratrol Enhances the Anti-Cancer Effects of Cis-Platinum on Human Cervical Cancer Cell Lines by Activating the SIRT3 Relative Anti-Oxidative Pathway.
    Front Pharmacol. 2022;13:916876.
    PubMed    
    Abstract available

  173. BHUVANENDRAN PILLAI A, Mun Wong C, Dalila Inche Zainal Abidin N, Fazlinda Syed Nor S, et al
    Chlamydia Infection as a Risk Factor for Cervical Cancer: A Systematic Review and Meta-Analysis.
    Iran J Public Health. 2022;51:508-517.
    PubMed    
    Abstract available

  174. ZENG GP, Sun R, Zhang SM, Yuan Y, et al
    Rare axillary metastases of cervical cancer: A case report.
    Asian J Surg. 2022 Jul 18. pii: S1015-9584(22)00984.
    PubMed    


  175. SHRESTHA AD, Andersen JG, Gyawali B, Shrestha A, et al
    Cervical cancer screening utilization, and associated factors, in Nepal: a systematic review and meta-analysis.
    Public Health. 2022;210:16-25.
    PubMed    
    Abstract available

  176. GIGLIO AG, de Brito Rangel J, Cardozo CL, Bergmann A, et al
    Incidence and risk factors associated with the development of metastatic spinal cord compression due to bone metastasis in women with cervical cancer.
    Eur Spine J. 2022 Jul 21. pii: 10.1007/s00586-022-07314.
    PubMed    
    Abstract available

  177. WU L, Gao J, Liu S, Jia Y, et al
    CircRNA circ_0005273 contributes to the cisplatin resistance of cervical cancer cells by sponging miR-133b.
    J Obstet Gynaecol. 2022 Jul 21:1-8. doi: 10.1080/01443615.2022.2099257.
    PubMed    
    Abstract available

  178. GERMANS N, Ellis P, Wilson S, Merriman A, et al
    The socioeconomic burden of a diagnosis of cervical cancer in women in rural Uganda: findings from a descriptive qualitative study.
    Int J Palliat Nurs. 2022;28:322-332.
    PubMed    
    Abstract available

  179. LI F, Shi D, Bu M, Lu S, et al
    Four-Dimensional Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Systematic Review and Meta-Regression Analysis.
    Front Oncol. 2022;12:870570.
    PubMed    
    Abstract available

  180. MO Y, Ma J, Zhang H, Shen J, et al
    Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives.
    Front Cell Infect Microbiol. 2022;12:909223.
    PubMed    
    Abstract available

  181. HOORSHAD N, Zamani N, Sheikh Hasani S, Poopak A, et al
    What are the determinants of parametrial invasion in patients with early stage cervical cancer: A cross sectional study.
    Ann Med Surg (Lond). 2022;79:104020.
    PubMed    
    Abstract available

  182. AUDIGER C, Bovagnet T, Bardes J, Abihsera G, et al
    Social Inequalities in Participation in Cervical Cancer Screening in a Metropolitan Area Implementing a Pilot Organised Screening Programme (Paris Region, France).
    Int J Public Health. 2022;67:1604562.
    PubMed    
    Abstract available

  183. MOTA AP, Aredes MA, De Oliveira Miguel J, Chaves GV, et al
    Nutritional status assessed by Patient-Generated Subjective Global Assessment is associated with toxicity to chemoradiotherapy in women with cervical cancer: a prospective study.
    Eur J Clin Nutr. 2022 Jul 19. pii: 10.1038/s41430-022-01180.
    PubMed    
    Abstract available

  184. LI Y, Diao Y, Wang Z, Wang S, et al
    The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5.
    Cell Death Discov. 2022;8:326.
    PubMed    
    Abstract available

  185. HOTT-SCHULZ K, Ramirez-Villalobos E, Ortega-Pena M, Santander-Cabello E, et al
    [Prevalence and genotypes of cervical and vaginal HPV in female sex workers attending a Sexual Control Centre, North Area of Santiago, Chile].
    Rev Chilena Infectol. 2022;39:117-125.
    PubMed    
    Abstract available

  186. CALO CA, Barrington DA, Brown M, Gonzalez L, et al
    High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors.
    Gynecol Oncol Rep. 2022;42:101040.
    PubMed    
    Abstract available


  187. Circular RNA circGSE1 Promotes Cervical Cancer Progression Through miR-138-5p/Vimentin [Retraction].
    Onco Targets Ther. 2022;15:759-760.
    PubMed    
    Abstract available


  188. Effects of Green Synthesised Silver Nanoparticles (ST06-AgNPs) Using Curcumin Derivative (ST06) on Human Cervical Cancer Cells (HeLa) in vitro and EAC Tumor Bearing Mice Models [Retraction].
    Int J Nanomedicine. 2022;17:3077-3078.
    PubMed    
    Abstract available

  189. SHEWALKAR B, Khan A, Yerlekar D, Patel J, et al
    Dose-Escalated Intensity-Modulated Radiotherapy for the Management of Locally Advanced Cervical Cancer.
    Cureus. 2022;14:e25965.
    PubMed    
    Abstract available

  190. ZHI W, Wei Y, Lazare C, Meng Y, et al
    HPV-CCDC106 integration promotes cervical cancer progression by facilitating high expression of CCDC106 after HPV E6 splicing.
    J Med Virol. 2022 Jul 19. doi: 10.1002/jmv.28009.
    PubMed    
    Abstract available

  191. LIU L, Yu C, Sun F, Yang T, et al
    Can preoperative ureteral stents reduce the incidence of ureteral stricture after radiotherapy in patients with cervical cancer?
    BMC Urol. 2022;22:106.
    PubMed    
    Abstract available

  192. CHIRWA GC
    Explaining socioeconomic inequality in cervical cancer screening uptake in Malawi.
    BMC Public Health. 2022;22:1376.
    PubMed    
    Abstract available

  193. SONG Y, Li R, Ye M, Pan C, et al
    Differences in chemotaxis of human mesenchymal stem cells and cervical cancer cells.
    Apoptosis. 2022 Jul 18. pii: 10.1007/s10495-022-01749.
    PubMed    
    Abstract available

  194. XU J, Huang Z, Wang Y, Xiang Z, et al
    Identification of Novel Tumor Microenvironment Regulating Factor That Facilitates Tumor Immune Infiltration in Cervical Cancer.
    Front Oncol. 2022;12:846786.
    PubMed    
    Abstract available

  195. LI P, Zhan X, Lv C, Lin Z, et al
    Comparison of the Oncological Outcomes Between Robot-Assisted and Abdominal Radical Hysterectomy for Cervical Cancer Based on the New FIGO 2018 Staging System: A Multicentre Retrospective Study.
    Front Oncol. 2022;12:879569.
    PubMed    
    Abstract available

  196. YANG S, Liu C, Li C, Hua K, et al
    Nomogram Predicting Lymph Node Metastasis in the Early-Stage Cervical Cancer.
    Front Med (Lausanne). 2022;9:866283.
    PubMed    
    Abstract available

  197. LIU Y, Li L, Yang Z, Wen D, et al
    Circular RNA circACAP2 Suppresses Ferroptosis of Cervical Cancer during Malignant Progression by miR-193a-5p/GPX4.
    J Oncol. 2022;2022:5228874.
    PubMed    
    Abstract available

  198. YANG D, Zhang J, Cui X, Ma J, et al
    Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening.
    Front Microbiol. 2022;13:914516.
    PubMed    
    Abstract available

  199. SHI YL, Liu MB, Wu HT, Han Y, et al
    GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer.
    Dis Markers. 2022;2022:9109365.
    PubMed    
    Abstract available

  200. CHEN F, Wang HM, Kong LQ, Chen QH, et al
    Synthesis and Anticancer Activity of Rhopaladins' Analog RPDPD Against the HeLa Human Cervical Cancer Cell Line.
    Front Chem. 2022;10:921276.
    PubMed    
    Abstract available

  201. PAWAR JS, Mustafa S, Ghosh I
    Chrysin and Capsaicin induces premature senescence and apoptosis via mitochondrial dysfunction and p53 elevation in Cervical cancer cells.
    Saudi J Biol Sci. 2022;29:3838-3847.
    PubMed    
    Abstract available

  202. AHMAD A, Tiwari RK, Mishra P, Alkhathami AG, et al
    Antiproliferative and apoptotic potential of Glycyrrhizin against HPV16+ Caski cervical cancer cells: A plausible association with downreguation of HPV E6 and E7 oncogenes and Notch signaling pathway.
    Saudi J Biol Sci. 2022;29:3264-3275.
    PubMed    
    Abstract available

  203. ZHANG X, Zhao J, Zhang Q, Wang S, et al
    MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Cancer Imaging. 2022;22:35.
    PubMed    
    Abstract available

  204. SULTANOV M, Zeeuw J, Koot J, der Schans JV, et al
    Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC).
    BMC Public Health. 2022;22:1356.
    PubMed    
    Abstract available

  205. KAMBLE A, Naik S, Talathi M, Jadhav D, et al
    Cervicovaginal microbiota isolated from healthy women exhibit probiotic properties and antimicrobial activity against pathogens isolated from cervical cancer patients.
    Arch Microbiol. 2022;204:491.
    PubMed    
    Abstract available

  206. GULTEKIN M, Beduk Esen CS, Ates Ozdemir D, Yildirim S, et al
    Stromal or intraepithelial tumor-infiltrating lymphocytes: which one has more prognostic significance in cervical cancer?
    Arch Gynecol Obstet. 2022 Jul 16. pii: 10.1007/s00404-022-06687.
    PubMed    
    Abstract available

  207. LANGBERG GSRE, Nygard JF, Gogineni VC, Nygard M, et al
    Towards a data-driven system for personalized cervical cancer risk stratification.
    Sci Rep. 2022;12:12083.
    PubMed    
    Abstract available

  208. BRUNI L, Serrano B, Roura E, Alemany L, et al
    Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
    Lancet Glob Health. 2022;10:e1115-e1127.
    PubMed    
    Abstract available

  209. LIU Y, Duan H, Dong D, Chen J, et al
    Development of a deep learning-based nomogram for predicting lymph node metastasis in cervical cancer: A multicenter study.
    Clin Transl Med. 2022;12:e938.
    PubMed    


  210. SSENTONGO P, McCall-Hosenfeld JS, Calo WA, Moss J, et al
    Association of human papillomavirus vaccination with cervical cancer screening: A systematic review and meta-analysis.
    Medicine (Baltimore). 2022;101:e29329.
    PubMed    
    Abstract available

  211. ADANE T, Getawa S
    The diagnostic accuracy of macrophage colony-stimulating factor for cervical cancer: A systematic review and meta-analysis.
    Medicine (Baltimore). 2022;101:e29538.
    PubMed    
    Abstract available

  212. CAROZZI FM, Yanez RR, Cannistra S, Matucci M, et al
    Feasibility of self-sampling and human papillomavirus testing in rural and urban areas for cervical cancer prevention in Bolivia: an observational study.
    Lancet Oncol. 2022;23 Suppl 1:S4.
    PubMed    
    Abstract available

  213. OSPINA-SERRANO AV, Bruges R, Ramos P, Bernal L, et al
    Impact of health insurance type on access to vaccination and mortality due to COVID-19 on patients with cancer in Colombia: a cohort study.
    Lancet Oncol. 2022;23 Suppl 1:S39.
    PubMed    
    Abstract available

  214. WONG EL, Wong CN, Cheung AW, Wong AY, et al
    Feasibility of human papillomavirus self-sampling to combat COVID-19-related disruptions to cervical cancer screening: a cross-sectional survey.
    Lancet Oncol. 2022;23 Suppl 1:S16.
    PubMed    
    Abstract available

  215. HU H, Fu M, Huang X, Huang J, et al
    Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis.
    Transl Cancer Res. 2022;11:1713-1721.
    PubMed    
    Abstract available

  216. JOUBERT KS, George BP, Razlog R, Abrahamse H, et al
    The In-Vitro Effect of Homeopathically Prepared Rubus idaeus and 680 nm Laser Irradiation on Cervical Cancer Cells.
    Homeopathy. 2022 Jul 14. doi: 10.1055/s-0042-1747683.
    PubMed    
    Abstract available

  217. ATHANASIOU A, Veroniki AA, Efthimiou O, Kalliala I, et al
    Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis.
    Lancet Oncol. 2022 Jul 11. pii: S1470-2045(22)00334.
    PubMed    
    Abstract available

  218. BOYARD J, Caille A, Brunet-Houdard S, Sengchanh-Vidal S, et al
    A Home-Mailed Versus General Practitioner-Delivered Vaginal Self-Sampling Kit for Cervical Cancer Screening: A Cluster Randomized Controlled Trial with a Cost-Effectiveness Analysis.
    J Womens Health (Larchmt). 2022 Jul 13. doi: 10.1089/jwh.2021.0597.
    PubMed    
    Abstract available

  219. DE BRITO RANGEL J, Giglio AG, Cardozo CL, Bergmann A, et al
    Prognostic factors for brain metastasis in women presenting cervical cancer.
    J Neurooncol. 2022 Jul 14. pii: 10.1007/s11060-022-04082.
    PubMed    
    Abstract available

  220. CHEN H, Zhao X, Li Y, Zhang S, et al
    High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
    Front Genet. 2022;13:908807.
    PubMed    
    Abstract available

  221. LI S, Li X, Zhang S, Feng Y, et al
    Association Between GSDMB Gene Polymorphism and Cervical Cancer in the Northeast Chinese Han Population.
    Front Genet. 2022;13:860727.
    PubMed    
    Abstract available

  222. KISSELJOVA NP, Fedorova MD, Zaikina AE, Elkina NV, et al
    [Identification regulatory noncoding RNAs of human papilloma virus type 16 (Papillomaviridae: Alphapapillomavirus: Human papillomavirus) in cervical tumors].
    Vopr Virusol. 2022;67:217-226.
    PubMed    
    Abstract available

  223. ZHANG T, Wang C, Wang K, Liang Y, et al
    RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK.
    Cell Death Dis. 2022;13:604.
    PubMed    
    Abstract available

  224. ROTELI-MARTINS CM, Magno V, Santos ALF, Teixeira JC, et al
    Human papillomavirus vaccination for adult women.
    Rev Bras Ginecol Obstet. 2022;44:631-635.
    PubMed    


  225. DUVLIS S, Dabeski D, Hiljadnikova-Bajro M, Osmani D, et al
    HPV E6/E7mRNA association with interleukin 10 (rs1800872) polymorphism in a group of Macedonian women.
    J Med Virol. 2022;94:4485-4489.
    PubMed    
    Abstract available

  226. PERKINS RB, Saslow D, Oliver K
    Long-Term Effectiveness of Human Papillomavirus Vaccination: Implications for Future Reduction in Cancer.
    Ann Intern Med. 2022 May 17. doi: 10.7326/M22-1309.
    PubMed    


  227. SANTELLA B, Schettino MT, Franci G, De Franciscis P, et al
    Microbiota and HPV: The role of viral infection on vaginal microbiota.
    J Med Virol. 2022;94:4478-4484.
    PubMed    
    Abstract available

  228. AGADAYI E, Karademir D, Karahan S
    Knowledge, Attitudes and Behaviors of Women who have or have not had human papillomavirus vaccine in Turkey about the Virus and the vaccine.
    J Community Health. 2022;47:650-657.
    PubMed    
    Abstract available

  229. MIAO C, Ma X, Fan J, Shi L, et al
    Methylparaben as a preservative in the development of a multi-dose HPV-2 vaccine.
    Hum Vaccin Immunother. 2022;18:2067421.
    PubMed    
    Abstract available

  230. SAITO M, Rajesh A, Innes C, van der Griend R, et al
    Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2.
    J Cancer Res Clin Oncol. 2022;148:1991-2002.
    PubMed    
    Abstract available

  231. ZHU K, Tian Y, Dong X, Akinwunmi BO, et al
    The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review.
    Arch Gynecol Obstet. 2022;306:173-187.
    PubMed    
    Abstract available

  232. SHINKAI S, Ishioka S, Mariya T, Fujibe Y, et al
    Does radical trachelectomy (RT) during pregnancy have higher obstetrical and oncological risks than RT before pregnancy?
    Arch Gynecol Obstet. 2022;306:189-197.
    PubMed    
    Abstract available

  233. MAOCHA IG, Carvalho J, Lopes-Nunes J, Rosado T, et al
    Drug Formulations for Localized Treatment of Human Papillomavirus-Induced Lesions.
    J Pharm Sci. 2022;111:2230-2238.
    PubMed    
    Abstract available

  234. SALOMON N, Selmi A, Grunwitz C, Kong A, et al
    Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16(+) cancer.
    Cancer Immunol Immunother. 2022;71:1975-1988.
    PubMed    
    Abstract available

  235. MOHAN N, V J, Prahladan A, K R, et al
    Impact of incorporating Magnetic Resonance Imaging in FIGO Staging of Primary Carcinoma Cervix: Experience from a tertiary cancer center.
    Asia Pac J Clin Oncol. 2022;18:465-472.
    PubMed    
    Abstract available

  236. WANG M, Perucho JAU, Vardhanabhuti V, Ip P, et al
    Radiomic Features of T2-weighted Imaging and Diffusion Kurtosis Imaging in Differentiating Clinicopathological Characteristics of Cervical Carcinoma.
    Acad Radiol. 2022;29:1133-1140.
    PubMed    
    Abstract available

  237. REBOLJ M, Pesola F, Mathews C, Mesher D, et al
    The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot.
    Br J Cancer. 2022 Mar 26. pii: 10.1038/s41416-022-01791.
    PubMed    
    Abstract available

  238. BOGANI G, Di Donato V, Muzii L, Casarin J, et al
    Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2022;275:64-69.
    PubMed    
    Abstract available

  239. TIDY JA, Brown BH
    Increased detection of high grade CIN, when using electrical impedance spectroscopy as an adjunct to routine colposcopy, is maintained when used across international boundaries: Prospective data from nine European countries.
    Eur J Obstet Gynecol Reprod Biol. 2022;275:41-45.
    PubMed    
    Abstract available

  240. ROGOWSKI P, Rottler M, Walter F, Saicic S, et al
    Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Gynecol Oncol. 2022 Jun 25. pii: S0090-8258(22)00423.
    PubMed    
    Abstract available

  241. BACORRO W, Baldivia K, Yu KK, Mariano J, et al
    Outcomes with definitive radiotherapy among patients with locally advanced cervical cancer with relative or absolute contraindications to cisplatin: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 Jun 24. pii: S0090-8258(22)00422.
    PubMed    
    Abstract available

  242. JACKSON CG, Moore KN, Cantrell L, Erickson BK, et al
    A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
    Gynecol Oncol. 2022 Apr 28. pii: S0090-8258(22)00257.
    PubMed    
    Abstract available

  243. CHERSTON C, Yoh K, Huang Y, Melamed A, et al
    Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer.
    Gynecol Oncol. 2022 Jul 1. pii: S0090-8258(22)00427.
    PubMed    
    Abstract available

  244. YOON M, Lee HK, Park EY, Kim JH, et al
    Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study.
    Int J Cancer. 2022 Jun 25. doi: 10.1002/ijc.34190.
    PubMed    
    Abstract available

  245. HUEPENBECKER S, Santia MC, Harrison R, Dos Reis R, et al
    Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer.
    Int J Gynecol Cancer. 2022 Jul 8. pii: ijgc-2022-003654.
    PubMed    
    Abstract available

  246. NASIOUDIS D, Rush M, Taunk NK, Ko EM, et al
    Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation.
    Int J Gynecol Cancer. 2022;32:823-827.
    PubMed    
    Abstract available

  247. PAREJA R
    Surgical staging for locally-advanced cervical cancer: the answer remains 'NO'.
    Int J Gynecol Cancer. 2022;32:828-829.
    PubMed    


  248. TENDOBI C, Fernandez-Marques M, Carlos S, Amann M, et al
    Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in Kinshasa, Democratic Republic of Congo.
    Int J Gynecol Cancer. 2022 Jul 20. pii: ijgc-2022-003592.
    PubMed    
    Abstract available

  249. GOUVEIA AG, Viani GA, Bratti VF, Pavoni JF, et al
    System-level capacity of high dose rate (HDR) brachytherapy for management of cervical cancer in an upper middle-income country: a case study from Brazil.
    Int J Radiat Oncol Biol Phys. 2022 Jun 29. pii: S0360-3016(22)00624.
    PubMed    
    Abstract available

  250. BARRY P, Beriwal S
    Combination of Knife and Rays with MRI-Guided Ablative Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2022;113:717-718.
    PubMed    


  251. CHOPRA S, Kalra B, Mulani J, Jain J, et al
    Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 15. pii: S0360-3016(22)00722.
    PubMed    
    Abstract available

  252. MULANI J, Jain J, Gupta A, Swamidas J, et al
    Dose Accumulation for Multicourse Gynecological Reirradiation: A Methodological Narrative and Clinical Examples.
    Int J Radiat Oncol Biol Phys. 2022;113:1085-1090.
    PubMed    
    Abstract available

  253. SHAH VI, McCluggage WG
    Clinical utility of pathology data: endometrial and tubo-ovarian carcinomas.
    J Clin Pathol. 2022;75:529-536.
    PubMed    
    Abstract available

  254. ARROYO MUHR LS, Eklund C, Lagheden C, Forslund O, et al
    Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study.
    J Clin Virol. 2022;154:105237.
    PubMed    
    Abstract available

  255. LIAO L, Chen L, Gockley A, Melamed A, et al
    Temporal Trends in Cervical Cancer Screening Practices and Associated Downstream Abnormalities and Procedures Among Women With Insurance in the United States.
    Obstet Gynecol. 2022;140:55-64.
    PubMed    
    Abstract available

  256. WANG Z, He S, Guo P, Guo X, et al
    [Retracted] MicroRNA1297 inhibits metastasis and epithelialmesenchymal transition by targeting AEG1 in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed    
    Abstract available

  257. DAVIDE C, Luca R, Benedetta G, Rosa A, et al
    Evaluation of early regression index as response predictor in cervical cancer: a retrospective study on T2 and DWI MR images.
    Radiother Oncol. 2022 Jul 7. pii: S0167-8140(22)04186.
    PubMed    
    Abstract available

  258. DANKULCHAI P, Harn-Utairasmee P, Prasartseree T, Nakkasae P, et al
    Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy.
    Radiother Oncol. 2022 Jul 12. pii: S0167-8140(22)04205.
    PubMed    
    Abstract available

  259. MAN X, Yang X, Wei Z, Tan Y, et al
    High expression level of CXCL1/GROalpha is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.
    BMC Cancer. 2022;22:712.
    PubMed    
    Abstract available

  260. CHEN J, Li C, Cao Y, Zhu L, et al
    Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
    BMC Cancer. 2022;22:793.
    PubMed    
    Abstract available

  261. HE Z, Chen R, Hu S, Zhang Y, et al
    The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.
    BMC Cancer. 2022;22:776.
    PubMed    
    Abstract available

  262. SINGH G, Sharma SK, Singh SK
    miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.
    BMC Cancer. 2022;22:777.
    PubMed    
    Abstract available

  263. SRIPAN P, Pongnikorn D, Chitapanarux I, Tangmunkongvorakul A, et al
    Geographical risk pattern and temporal trends in incidence of HPV-related cancers in northern Thailand: A population-based study.
    PLoS One. 2022;17:e0270670.
    PubMed    
    Abstract available

  264. LEMMA D, Aboma M, Girma T, Dechesa A, et al
    Determinants of utilization of cervical cancer screening among women in the age group of 30-49 years in Ambo Town, Central Ethiopia: A case-control study.
    PLoS One. 2022;17:e0270821.
    PubMed    
    Abstract available

  265. EL MANSOURI N, Ferrera L, Kharbach A, Achbani A, et al
    Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study.
    PLoS One. 2022;17:e0271222.
    PubMed    
    Abstract available

  266. KIM M, Kim J, Park NJ, Park JY, et al
    Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.
    PLoS One. 2022;17:e0267836.
    PubMed    
    Abstract available

  267. BARRERA FERRO D, Bayer S, Bocanegra L, Brailsford S, et al
    Understanding no-show behaviour for cervical cancer screening appointments among hard-to-reach women in Bogota, Colombia: A mixed-methods approach.
    PLoS One. 2022;17:e0271874.
    PubMed    
    Abstract available

  268. AYANTO SY, Belachew T, Wordofa MA
    Effectiveness of couple education and counseling on knowledge, attitude and uptake of cervical cancer screening service among women of child bearing age in Southern Ethiopia: A cluster randomized trial protocol.
    PLoS One. 2022;17:e0270663.
    PubMed    
    Abstract available

  269. YANG Z, Liu J, Wang Q
    Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.
    PLoS One. 2022;17:e0270347.
    PubMed    
    Abstract available

  270. SHIMELS T, Gashaw B, Gedif T
    Association between delayed initiation of treatment indications and survival in patients with cervical cancer: A systematic review and meta-analysis protocol.
    PLoS One. 2022;17:e0271604.
    PubMed    
    Abstract available

  271. BEYEN MW, Bulto GA, Chaka EE, Debelo BT, et al
    Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    PLoS One. 2022;17:e0271237.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;